ANI Pharmaceuticals Files 8-K Report

Ticker: ANIP · Form: 8-K · Filed: Jul 23, 2025 · CIK: 1023024

Ani Pharmaceuticals Inc 8-K Filing Summary
FieldDetail
CompanyAni Pharmaceuticals Inc (ANIP)
Form Type8-K
Filed DateJul 23, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 8-K, financials, operations

Related Tickers: ANPH

TL;DR

ANI Pharma filed an 8-K on 7/23/25 covering financials and operations.

AI Summary

On July 23, 2025, ANI Pharmaceuticals, Inc. filed an 8-K report. The filing indicates the company's principal executive offices are located at 210 Main Street West, Baudette, Minnesota. The report covers items related to the results of operations and financial condition, Regulation FD disclosure, other events, and financial statements and exhibits.

Why It Matters

This 8-K filing provides an update on ANI Pharmaceuticals' operational and financial status, which is crucial for investors to assess the company's performance and future prospects.

Risk Assessment

Risk Level: low — This filing is a routine 8-K report detailing operational and financial information, not indicating any immediate significant risks.

Key Players & Entities

  • ANI PHARMACEUTICALS, INC. (company) — Registrant
  • 210 Main Street West, Baudette, Minnesota (location) — Principal executive offices
  • July 23, 2025 (date) — Date of Report

FAQ

What is the primary purpose of this 8-K filing by ANI Pharmaceuticals, Inc.?

The 8-K filing reports on the Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits of ANI Pharmaceuticals, Inc.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on July 23, 2025.

What is the address of ANI Pharmaceuticals, Inc.'s principal executive offices?

The principal executive offices of ANI Pharmaceuticals, Inc. are located at 210 Main Street West, Baudette, Minnesota, 56623.

What is the Commission File Number for ANI Pharmaceuticals, Inc.?

The Commission File Number for ANI Pharmaceuticals, Inc. is 001-31812.

What is the I.R.S. Employer Identification No. for ANI Pharmaceuticals, Inc.?

The I.R.S. Employer Identification No. for ANI Pharmaceuticals, Inc. is 58-2301143.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 23, 2025 regarding ANI PHARMACEUTICALS INC (ANIP).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.